Assignee
ENDO PHARMACEUTICALS INC
US·21 granted patents·29 pending applications·445 citations·filing 1996–2022
Top patents by PatentIndex Score
50 records- 0195US6562835B1Method for the treatment of urinary incontinenceENDO PHARMACEUTICALS INC·Filed 1996·Granted May 13, 2003·130 cites·8 claims
- 0294US6277398B1Analgesic drug composition containing a capsaicinoid and potentiator thereforENDO PHARMACEUTICALS INC·Filed 1999·Granted Aug 21, 2001·144 cites·16 claims
- 0386US6406716B2Anticonvulsant containing composition for treating neuropathic painENDO PHARMACEUTICALS INC·Filed 2001·Granted Jun 18, 2002·27 cites·46 claims
- 0485US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 0583US8685418B2CyclohexylaminesENDO PHARMACEUTICALS INC·Filed 2012·Granted Apr 1, 2014·6 cites·1 claims
- 0682US6166211ASequential benzylic oxidations of the naloxone ring systemENDO PHARMACEUTICALS INC·Filed 2000·Granted Dec 26, 2000·19 cites·12 claims
- 0778US5955475AProcess for manufacturing paroxetine solid dispersionsENDO PHARMACEUTICALS INC·Filed 1997·Granted Sep 21, 1999·57 cites·27 claims
- 0878US2009192183A1Oxymorphone Controlled Release FormulationsENDO PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0976US6825217B2Carbinols for the treatment of neuropathic dysfunctionENDO PHARMACEUTICALS INC·Filed 2002·Granted Nov 30, 2004·10 cites·58 claims
- 1076US2008262013A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1175US9789103B2Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairmentENDO PHARMACEUTICALS INC·Filed 2014·Granted Oct 17, 2017·3 cites·61 claims
- 1275US2021008063A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1375US2015011577A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1474US2018338967A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1573US9351938B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·1 cites·24 claims
- 1673US7501452B2Treatment of xerostomiaENDO PHARMACEUTICALS INC·Filed 2006·Granted Mar 10, 2009·5 cites·23 claims
- 1773US2022313688A1Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairmentENDO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1872US11389443B2Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairmentENDO PHARMACEUTICALS INC·Filed 2017·Granted Jul 19, 2022·1 cites·8 claims
- 1971US10052344B2Vitamin B12 nasal spray and method of useENDO PHARMACEUTICALS INC·Filed 2015·Granted Aug 21, 2018·1 cites·42 claims
- 2071US6168805B1Aqueous process for manufacturing paroxetine solid dispersionsENDO PHARMACEUTICALS INC·Filed 1998·Granted Jan 2, 2001·32 cites·33 claims
- 2171US2014134250A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2270US9186330B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·1 cites·37 claims
- 2368US9440986B2Crystalline, anhydrous forms of oxymorphone hydrochlorideENDO PHARMACEUTICALS INC·Filed 2015·Granted Sep 13, 2016·1 cites·13 claims
- 2468US2008069881A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2567US10406106B2Sustained release formulations of nalbuphineENDO PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·0 cites·21 claims
- 2667US2013172382A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2766US2016136152A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2863US10172798B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·0 cites·24 claims
- 2962US2019216842A1Vitamin b12 nasal spray and method of useENDO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3061US2008226702A1Transdermal Delivery Form Disposal Systems and MethodsENDO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3159US9926328B2Crystalline, anhydrous forms of oxymorphone hydrochlorideENDO PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·0 cites·13 claims
- 3257US2014073782A1Substituted Quinazoline and Pyrido-Pyrimidine DerivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3357US2016263035A1Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3457US2003065002A1Abuse-resistant controlled-release opioid dosage formENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3556US2008318994A1Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal ImpairmentENDO PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3656US2013190492A1Substituted quinazoline and pyrido-pyrimidine derivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3754US7087619B2Method for the treatment of urinary incontinenceENDO PHARMACEUTICALS INC·Filed 2003·Granted Aug 8, 2006·0 cites·10 claims
- 3854US2013209561A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3952US2009124650A1Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of AlcoholENDO PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4052US2006147510A1Method for treating non-neuropathic painENDO PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4152US2008318993A1Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic ImpairmentENDO PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4250US5808090AProcess for preventing precipitation in cimetidine injection solutionsENDO PHARMACEUTICALS INC·Filed 1997·Granted Sep 15, 1998·4 cites·25 claims
- 4350US2011135731A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4449US2011020444A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4546US2003004177A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4646US2003124174A1Method for treating non-neuropathic painENDO PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4744US2016074041A1Urethral anastomosis device and methodENDO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4843US2015250479A1Urethral anastomosis device and methodENDO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4941US2003064122A1Abuse resistant pharmaceutical composition containing capsaicinENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 5041US2015245839A1Urethral anastomosis device and methodENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ENDO PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →